50 million Americans due for colon cancer screening avoid it because ... the paperwork required to receive an at-home stool-based screening test. When Dennis saw his doctor recently — still ...

Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...

(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has ...

The FDA recently approved Guardant Health’s “Shield” blood test for colorectal cancer (CRC) screening in adults aged 45 and older who are at average risk for the disease. It is the first blood test to ...

New Study Shows at-Home Colon Cancer Screening Test Reduces Risk of Colorectal Cancer Death, as Effective as Screening Colonoscopy July 25, 2024 — A noninvasive colorectal cancer screening test ...

In addition, Mainz Biomed will provide Quest with the option to exercise semi-exclusive rights to provide testing services based on the test kit ... for colon cancer. This gap in screening ...

Mainz Biomed’s stool-based ColoAlert test ... test kit for an eighteen-month period, assuming its approval by the FDA. Colorectal cancer (CRC) is the third most common cancer globally, with more than ...